Inducible mutagenesis of target genes
View Patent ↗The present invention relates generally to mutagenesis of target genes that takes advantage of the natural mutagenic capabilities of B cells, and enhances those capabilities by bringing the process of diversification under control. The invention provides a method for rapidly and inducibly generating point mutations and other types of diversification in expressed genes, such as antibody genes. This method can be coupled with selection to identify B cell clones that produce, for example, antibodies of high affinity or specificity. The diversification process can be modulated, accelerated, halted, switched between methods of mutagenesis and the like. The modulation of diversification in accordance with the invention is both inducible and reversible. The invention provides a means of rapid and feasible development of a repertoire of variant immunoglobulins and other polypeptides.
1. A method of producing B cells that produce an optimized polypeptide of interest, the method comprising:
(a) culturing a B cell modified to reversibly induce accelerated diversification of a target gene containing a coding region of the polypeptide of interest in conditions that allow expression of the diversification factor, wherein said B cell expresses the polypeptide of interest on the surface of the B cell and wherein said B cell comprises:
(i) a cis-regulatory element operably linked to the target gene, wherein the target gene comprises a promoter and a coding region; and
(ii) a fusion construct that encodes a tethering factor fused to a diversification factor, wherein the tethering factor specifically binds to the cis-regulatory element of (a) and the diversification factor reversibly induces accelerated diversification of the coding region in the target gene;
(b) selecting cells from the culture that bind a ligand that specifically binds the polypeptide of interest expressed on the B cell surface; and
(c) repeating steps (a) and (b) until cells are selected that have a desired affinity for the ligand that specifically binds the polypeptide of interest.
2. The method of claim 1 , wherein the B cell is a DT40 chicken B cell.
3. The method of claim 1 , wherein the B cell is a human B cell.
4. The method of claim 1 , wherein the cis-regulatory element is a polymerized Lactose operator (LacO) and the tethering factor is a lactose repressor (LacI).
5. The method of claim 1 , wherein the cis-regulatory element is a tetracycline operator (TetO) and the tethering factor is tetracycline repressor (TetR).
6. The method of claim 1 , wherein the diversification factor is at least one of a transcriptional regulator, a heterochromatin-associated protein, a histone chaperone, a chromatin remodeler, a component of the nuclear pore complex, a gene regulator, or a combination thereof.
7. The method of claim 1 , wherein the diversification factor is a DNA repair factor, a DNA replication factor, a resolvase, a helicase, a cell cycle regulator, a ubquitylation factor, a sumoylation factor, or a combination thereof.
8. The method of claim 6 , wherein the transcriptional regulator is VP16 or E47.
9. The method of claim 6 , wherein the heterochromatin-associated protein is HP1.
10. The method of claim 6 , wherein the histone chaperone is HIRA.
11. The method of claim 1 , wherein the polypeptide of interest is an Ig.
12. The method of claim 11 , wherein the Ig is an IgL, IgH or both.
13. The method of claim 1 , wherein culturing the B cell in conditions that allow expression of the diversification factor according to step (a) comprises adding a regulatory molecule to the culture, wherein the regulatory molecule modulates binding of the tethering factor to the cis-regulatory element, thereby modulating accelerated diversification of the coding region in the target gene.
14. The method of claim 1 , wherein culturing the B cell in conditions that allow expression of the diversification factor according to step (a) comprises removing a regulatory molecule from the culture, wherein the regulatory molecule modulates binding of the tethering factor to the cis-regulatory element, thereby modulating accelerated diversification of the coding region in the target gene.
15. The method of claim 1 , wherein culturing the B cell in conditions that allow expression of the diversification factor according to step (a) comprises modulating expression of a regulatory gene in the B cell, wherein the regulatory gene regulates diversification, thereby modulating accelerated diversification of the coding region that encodes the polypeptide of interest.